The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non‐responders. Issue 7 (20th May 2018) - Stitt, J. M.; Dzieciatkowska, M.; Edwards, M. G.; Hansen, K.; Hedlund, G.; Dreskin, S. C.